Literature DB >> 26393187

Disseminated Cutaneous Herpes Zoster in a Patient with Uncontrolled Diabetes Mellitus.

Shashikant Malkud1, Santosh M Patil2.   

Abstract

Herpes zoster is a clinical manifestation which results from reactivation of latent VZV (Varicella zoster virus) present in the sensory root ganglia. Disseminated herpes zoster has been reported in immune-compromised patients such as patient on cancer chemotherapy, HIV (Human immune deficiency virus) infection, systemic corticosteroid therapy. However, we report a case of disseminated herpes zoster infection in an uncontrolled diabetic patient. A brief review of literature on this topic has been bestowed.

Entities:  

Keywords:  Cell mediated immunity; Dermatome; Systemic corticosteroid therapy

Year:  2015        PMID： 26393187      PMCID： PMC4573019          DOI： 10.7860/JCDR/2015/12242.6240

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN： 0973-709X


  9 in total

1.  Disseminated "shingles" in the nephrotic syndrome.

Authors:  Sunil Kumar; A P Jain
Journal:  Saudi J Kidney Dis Transpl       Date:  2010-11

2.  Herpes generalisata assoicated with diabetes mellitus and pulmonary tuberculosis (a case report).

Authors:  R B Panwar; D K Kochar; B S Gupta; L K Bhatnagar; H C Saxena
Journal:  J Postgrad Med       Date:  1979-07       Impact factor: 1.476

3.  A case of human immunodeficiency virus infection initially presented with disseminated herpes zoster.

Authors:  Bong Seok Shin; Chan Ho Na; In Guk Song; Kyu Chul Choi
Journal:  Ann Dermatol       Date:  2010-05-18       Impact factor: 1.444

4.  Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel.

Authors:  A D Heymann; G Chodick; T Karpati; L Kamer; E Kremer; M S Green; E Kokia; V Shalev
Journal:  Infection       Date:  2008-05-03       Impact factor: 3.553

5.  Undiagnosed diabetes mellitus in patients with Herpes Zoster.

Authors:  Mohammad Nassaji-Zavareh; Ramin Taheri; Raheb Ghorbani; Maryam Aminian
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

6.  Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals.

Authors:  Shigefumi Okamoto; Atsuko Hata; Kay Sadaoka; Koichi Yamanishi; Yasuko Mori
Journal:  J Infect Dis       Date:  2009-11-15       Impact factor: 5.226

7.  [Disseminated herpes zoster in diabetes mellitus].

Authors:  N Graue; S Grabbe; J Dissemond
Journal:  Dtsch Med Wochenschr       Date:  2006-02-24       Impact factor: 0.628

8.  [Herpes zoster incidence in diabetic patients].

Authors:  P Aldaz; J A Díaz; J R Loayssa; M J Dronda; M Oscáriz; J Castilla
Journal:  An Sist Sanit Navar       Date:  2013 Jan-Apr       Impact factor: 0.829

9.  Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study.

Authors:  A Hata; M Kuniyoshi; Y Ohkusa
Journal:  Infection       Date:  2011-07-29       Impact factor: 3.553
  9 in total
  3 in total

1.  Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report.

Authors:  Masato Habuka; Yoko Wada; Yoichi Kurosawa; Suguru Yamamoto; Yusuke Tani; Riuko Ohashi; Yoichi Ajioka; Masaaki Nakano; Ichiei Narita
Journal:  BMC Res Notes       Date:  2018-03-05

2.  Visceral disseminated varicella zoster infection: a rare cause of acute abdomen in a patient with well-controlled diabetes mellitus-a case report.

Authors:  Daisuke Mizu; Haruka Nishida; Yoshinori Matsuoka; Koichi Ariyoshi
Journal:  BMC Infect Dis       Date:  2022-03-03       Impact factor: 3.090

3.  Elsberg syndrome related to varicella zoster virus infection with painless skin lesions in an elderly woman with poorly controlled type 2 diabetes mellitus.

Authors:  Hitoki Saito; Momoko Ebashi; Masaru Kushimoto; Jin Ikeda; Fujiko Egashira; Suguru Yamaguchi; Kentaro Watanabe; Katsuhiko Ogawa; Yutaka Suzuki; Hisamitsu Ishihara; Midori Fujishiro
Journal:  Ther Clin Risk Manag       Date:  2018-10-09       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.